How compatible are immune checkpoint inhibitors and thermal ablation for liver metastases?

HIGHLIGHTS

  • who: Yasunori Minami et al. from the Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University have published the article: How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?, in the Journal: Cancers 2022, 2206 of /2022/

SUMMARY

    The enhancement of antitumor immune_responses, as a strategy to overcome resistance to ICIs, is urgently needed. Locoregional thermal ablation has the potential to promote anticancer immune_responses, and a very rare event associated with this therapy is the abscopal effect, which induces spontaneous distant tumor regression. The combination of tumor-intrinsic and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?